Glioblastoma treatment with the anticancer drug epidermal growth factor receptor‐targeted diphtheria toxin (DT‐ EGF) induces autophagy and HMGB1 release from tumor cells, and HMGB1 release is greatly reduced with autophagy inhibition. This evidence concerns the gene HMGB1 and neoplasm.